DV
Dividend Vision

ISCO — International Stem Cell Corp

International Stem Cell Corp (ISCO)

Its deepest 1-year drawdown was 36.8%.

International Stem Cell Corp is an equity stock focused on the international stem cell sector. The fund does not currently pay distributions to shareholders and lacks readily available data on expense ratio and assets under management. This fund appeals to investors seeking exposure to stem cell research and development rather than those prioritizing dividend income.

ISCO key facts

Asset type
Stock
Asset class
Equity
Inception date
01/08/2007
Distribution frequency
None
Last close
$0.35
Market cap
$2,801,536
Average volume
400.0
Beta
-0.047
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.05